þð :È­ÇÐÁ¦Ç°Á¤º¸[È­ÇÐDatabase] - ÀÎÆ÷Äͽº(ÁÖ) .asat{position:absolute;clip:rect(479px,auto,auto,479px);}");
þð,H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH">
È­ÇÐDB °³¿ä  |  È­ÇÐÁ¦Ç°[Product]  |  È­Çй°Áú[Chemical]  |  È­Çо÷ü[Company]
Glucagon (1-29) (human) Hydrochloride
H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OH
16941-32-5(net)
For the treatment of hypoglycemia (diabetes mellitus).
Glucagon opposes the action of insulin. It enhances the synthesis and mobilization of glucose in the liver.
Á¦Ç°°ü·ÃºÐ¾ß ÀǾà,Áß°£Ã¼
Sinopep Pharmaceutical Inc.
ÀüÈ­¹øÈ£ 008657128918380
Æѽº¹øÈ£ 008657128918368
ȨÆäÀÌÁö www.sinopep.com
À̸ÞÀÏ market@sinopep.com
ÁÖ¼Ò No.1180 Bin'an Road
ÀÌÁ¦Ç°¿¡ ´ëÇØ µî·ÏµÈ ÆǸž÷ü°¡ ¾ø½À´Ï´Ù.